CN1517395A - 茴香烯的羟丙基-β-环糊精包合物及其制剂和制备方法 - Google Patents
茴香烯的羟丙基-β-环糊精包合物及其制剂和制备方法 Download PDFInfo
- Publication number
- CN1517395A CN1517395A CNA03110875XA CN03110875A CN1517395A CN 1517395 A CN1517395 A CN 1517395A CN A03110875X A CNA03110875X A CN A03110875XA CN 03110875 A CN03110875 A CN 03110875A CN 1517395 A CN1517395 A CN 1517395A
- Authority
- CN
- China
- Prior art keywords
- beta
- hydroxypropyl
- cyclodextrin
- methyl ether
- anethole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 title claims abstract description 130
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 title claims abstract description 70
- 150000001875 compounds Chemical class 0.000 title claims abstract description 47
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 title claims abstract description 24
- 229940011037 anethole Drugs 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- 239000000243 solution Substances 0.000 claims abstract description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000000843 powder Substances 0.000 claims abstract description 13
- 238000003756 stirring Methods 0.000 claims abstract description 8
- 238000002347 injection Methods 0.000 claims abstract description 7
- 239000007924 injection Substances 0.000 claims abstract description 7
- 239000003960 organic solvent Substances 0.000 claims abstract description 6
- 239000002994 raw material Substances 0.000 claims abstract description 5
- 239000007864 aqueous solution Substances 0.000 claims abstract description 4
- 239000006190 sub-lingual tablet Substances 0.000 claims abstract description 3
- 229940098466 sublingual tablet Drugs 0.000 claims abstract description 3
- 238000000034 method Methods 0.000 claims description 20
- 239000000203 mixture Substances 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 239000012982 microporous membrane Substances 0.000 claims description 6
- 229920000858 Cyclodextrin Polymers 0.000 claims description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 4
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 230000010355 oscillation Effects 0.000 claims description 4
- 239000001116 FEMA 4028 Substances 0.000 claims description 3
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims description 3
- 229960004853 betadex Drugs 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 3
- 238000011082 depyrogenation Methods 0.000 claims description 3
- 238000005374 membrane filtration Methods 0.000 claims description 3
- 238000005498 polishing Methods 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 239000012153 distilled water Substances 0.000 claims description 2
- 239000000178 monomer Substances 0.000 claims description 2
- 239000012528 membrane Substances 0.000 abstract description 2
- BHAAPTBBJKJZER-UHFFFAOYSA-N p-anisidine Chemical compound COC1=CC=C(N)C=C1 BHAAPTBBJKJZER-UHFFFAOYSA-N 0.000 abstract 2
- 239000002671 adjuvant Substances 0.000 abstract 1
- 238000004108 freeze drying Methods 0.000 abstract 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 14
- 238000002329 infrared spectrum Methods 0.000 description 9
- 238000013019 agitation Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000004809 thin layer chromatography Methods 0.000 description 4
- 238000000108 ultra-filtration Methods 0.000 description 4
- 239000000284 extract Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- ZEYHEAKUIGZSGI-UHFFFAOYSA-N 4-methoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C=C1 ZEYHEAKUIGZSGI-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- LHXDLQBQYFFVNW-UHFFFAOYSA-N Fenchone Chemical compound C1CC2(C)C(=O)C(C)(C)C1C2 LHXDLQBQYFFVNW-UHFFFAOYSA-N 0.000 description 2
- 206010018910 Haemolysis Diseases 0.000 description 2
- 240000007232 Illicium verum Species 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000012259 ether extract Substances 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 238000003822 preparative gas chromatography Methods 0.000 description 2
- 239000013558 reference substance Substances 0.000 description 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- LHXDLQBQYFFVNW-XCBNKYQSSA-N (+)-Fenchone Natural products C1C[C@]2(C)C(=O)C(C)(C)[C@H]1C2 LHXDLQBQYFFVNW-XCBNKYQSSA-N 0.000 description 1
- 239000001074 1-methoxy-4-[(E)-prop-1-enyl]benzene Substances 0.000 description 1
- 239000001169 1-methyl-4-propan-2-ylcyclohexa-1,4-diene Substances 0.000 description 1
- 235000014493 Crataegus Nutrition 0.000 description 1
- 241001092040 Crataegus Species 0.000 description 1
- 241000125183 Crithmum maritimum Species 0.000 description 1
- 240000006927 Foeniculum vulgare Species 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 235000008227 Illicium verum Nutrition 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 244000180308 Ocimum basilicum Species 0.000 description 1
- 240000004760 Pimpinella anisum Species 0.000 description 1
- 235000012550 Pimpinella anisum Nutrition 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 1
- QNBLWPGKPNANOY-UHFFFAOYSA-N benzene-1,3,5-triol;hydrochloride Chemical group Cl.OC1=CC(O)=CC(O)=C1 QNBLWPGKPNANOY-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000002026 carminative effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000003749 cleanliness Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000010812 external standard method Methods 0.000 description 1
- 229930006735 fenchone Natural products 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- -1 methyl allylphenol Chemical compound 0.000 description 1
- 229940096978 oral tablet Drugs 0.000 description 1
- 239000007935 oral tablet Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 150000007875 phellandrene derivatives Chemical class 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229940023488 pill Drugs 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000011146 sterile filtration Methods 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 03110875 CN1276016C (zh) | 2003-01-16 | 2003-01-16 | 茴香烯的β-环糊精包合物及其制剂和制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 03110875 CN1276016C (zh) | 2003-01-16 | 2003-01-16 | 茴香烯的β-环糊精包合物及其制剂和制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1517395A true CN1517395A (zh) | 2004-08-04 |
CN1276016C CN1276016C (zh) | 2006-09-20 |
Family
ID=34283287
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 03110875 Expired - Fee Related CN1276016C (zh) | 2003-01-16 | 2003-01-16 | 茴香烯的β-环糊精包合物及其制剂和制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1276016C (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102225208A (zh) * | 2011-06-20 | 2011-10-26 | 成都蓉药集团四川长威制药有限公司 | 柠檬烯包合物及其制备方法 |
CN107496355A (zh) * | 2017-08-24 | 2017-12-22 | 青岛正大海尔制药有限公司 | 一种盐酸环苯扎林舌下喷雾剂及其制备方法 |
-
2003
- 2003-01-16 CN CN 03110875 patent/CN1276016C/zh not_active Expired - Fee Related
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102225208A (zh) * | 2011-06-20 | 2011-10-26 | 成都蓉药集团四川长威制药有限公司 | 柠檬烯包合物及其制备方法 |
CN102225208B (zh) * | 2011-06-20 | 2012-07-25 | 成都蓉药集团四川长威制药有限公司 | 柠檬烯包合物及其制备方法 |
CN107496355A (zh) * | 2017-08-24 | 2017-12-22 | 青岛正大海尔制药有限公司 | 一种盐酸环苯扎林舌下喷雾剂及其制备方法 |
CN107496355B (zh) * | 2017-08-24 | 2021-04-30 | 正大制药(青岛)有限公司 | 一种盐酸环苯扎林舌下喷雾剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1276016C (zh) | 2006-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100387588C (zh) | 从植物中提取杨梅树皮素的方法 | |
Yoza et al. | Sugar-integrated gelators of organic fluids: on their versatility as building-blocks and diversity in superstructures | |
WO1989009235A1 (en) | Substituted cyclodextrins and process for chromatographic separation of chiral organic compounds | |
CN101928356A (zh) | 双-[6-氧-(2-间羧基苯磺酰基-丁二酸1,4单酯-4)]-β-环糊精及制备方法和用途 | |
AU688440B2 (en) | Cyclodextrin derivatives for solubilising hydrophobic chemical compounds such as drugs, and methods for preparing same | |
JPS60226830A (ja) | 1,3−グルカンより成る分離剤 | |
CN1323312A (zh) | 盐酸阿霉素的结晶 | |
CN1276016C (zh) | 茴香烯的β-环糊精包合物及其制剂和制备方法 | |
CN105148884B (zh) | 一种用于外消旋体拆分的石英毛细管手性分离柱及其制备方法 | |
Bhacca et al. | Carbon-13 magnetic resonance study of terpenoids. I. Application of heteronuclear selective decoupling experiments to the spectral assignments of nonproton-bearing carbon-13 resonances of a germacranolide, melampodin | |
CN1195527C (zh) | 莪术油的羟丙基-β-环糊精包合物及制剂和制备方法 | |
CN1290914C (zh) | 榄香烯的羟丙基-β-环糊精包合物及其制剂和制备方法 | |
CN1392135A (zh) | 大孔吸咐树脂法富集与纯化辣椒碱的方法 | |
CN1517091A (zh) | 黄体酮制剂及制备方法 | |
CN1326343A (zh) | 降促乳素药物 | |
CN112604675B (zh) | 一种偶氮苯二甲酰胺基桥联β-环糊精手性固定相的制备方法及其用途 | |
CN103910812B (zh) | β-环糊精衍生物和其制备方法以及由其制备的多脲键环糊精手性固定相 | |
CN1176904C (zh) | 分子蒸馏法富集与纯化辣椒碱的方法 | |
Lv et al. | Enantiomeric resolution of new triazole compounds by high‐performance liquid chromatography | |
JP2986592B2 (ja) | 24―ヒドロキシコレステロール誘導体の24位エピマーの分離法 | |
Salvadori et al. | Chiral stationary phase derived from l-lactic acid for the optical resolution of N-(3, 5-dinitrobenzoyl) amino acid methyl esters | |
CN108872409A (zh) | 一种特定分子量透明质酸分离纯化的方法 | |
JPH09506921A (ja) | 疎水性化合物を溶解するためおよびエナンチオマの純度を照査するためのモノ−3,6−アンヒドロシクロデキストリンの使用およびこれらのシクロデキストリンの調製方法 | |
Sutherland et al. | Separation of quinoxaline antibiotics by coil planet centrifugation | |
JP6982262B2 (ja) | 精製方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SHENYANG HAOTIAN WANJIA PHARMACEUTICAL TECHNOLOGY Free format text: FORMER OWNER: DONG YINGJIE Effective date: 20080201 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20080201 Address after: Liaoning province in Dongling District of Shenyang City fengle Street No. 86 A Patentee after: Shenyang Haotian Wanjia Pharmaceutical Technology Co., Ltd. Address before: Fang LAN Lu 170000 in Dongling District of Shenyang city in Liaoning Province in the new East Qing Yuan building 12 room 1 - 5 - 1 Patentee before: Dong Yingjie |
|
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Xi'an Haotian Bioengineering Tech. Co., Ltd. Assignor: Shenyang Haotian Wanjia Pharmaceutical Technology Co., Ltd. Contract fulfillment period: 2008.1.10 to 2023.1.10 contract change Contract record no.: 2008210000017 Denomination of invention: Hydroxy propyl-beta-cyclodextrin inclusion compound of anisolene and its preparation and preparation method Granted publication date: 20060920 License type: exclusive license Record date: 2008.5.28 |
|
LIC | Patent licence contract for exploitation submitted for record |
Free format text: EXCLUSIVE LICENCE; TIME LIMIT OF IMPLEMENTING CONTACT: 2008.1.10 TO 2023.1.10 Name of requester: XI AN HAOTIAN BIOTECHNOLOGY LIMITED LIABILITY COM Effective date: 20080528 |
|
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060920 Termination date: 20120116 |